Exterol 5% w/w Ear Drops, Solution

  • Name:

    Exterol 5% w/w Ear Drops, Solution

  • Company:
    info
  • Active Ingredients:

    Urea Hydrogen Peroxide

  • Legal Category:

    Supply through pharmacy only

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 10/07/15

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 31/8/2018

Click on this link to Download PDF directly

Dermal Laboratories Limited

Dermal Laboratories Limited

Company Products

Medicine NameActive Ingredients
Medicine Name Anhydrol Forte 20% w/v Cutaneous Solution Active Ingredients Aluminium Chloride Hexahydrate
Medicine Name Betacap Scalp Application 0.1% w/w Cutaneous Solution Active Ingredients Betamethasone Valerate
Medicine Name Capasal Therapeutic Shampoo Active Ingredients Coconut Oil, Distilled Coal Tar, Salicylic Acid
Medicine Name Dioderm 0.1% w/w Cream Active Ingredients Hydrocortisone
Medicine Name Dithrocream Active Ingredients Dithranol
Medicine Name Emulsiderm Emollient Bath Additive/Cutaneous Emulsion Active Ingredients Benzalkonium Chloride, Isopropyl Myristate, Liquid Paraffin
Medicine Name Exterol 5% w/w Ear Drops, Solution Active Ingredients Urea Hydrogen Peroxide
Medicine Name Glutarol 10% w/v Cutaneous Solution Active Ingredients Glutaraldehyde
Medicine Name Ibugel 5% w/w Gel Active Ingredients Ibuprofen
Medicine Name Nicam 4% w/w Gel Active Ingredients Nicotinamide
Medicine Name Perinal Cutaneous Spray Active Ingredients Hydrocortisone, Lidocaine Hydrochloride
Medicine Name Psoriderm Cream Active Ingredients Distilled Coal Tar
Medicine Name Psoriderm Emulsion 40% w/v Bath Additive Active Ingredients Distilled Coal Tar
Medicine Name Psoriderm Scalp Lotion Shampoo Active Ingredients Distilled Coal Tar
Medicine Name Salactol Collodion Active Ingredients Lactic Acid, Salicylic Acid
Medicine Name Salatac Gel Active Ingredients Lactic Acid, Salicylic Acid
1 - 0 of 16 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 31 August 2018 SmPC

Reasons for updating

  • File format updated to PDF

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

File format updated to PDF

Updated on 10 July 2015 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Supply through pharmacy only

Updated on 10 July 2015 PIL

Reasons for updating

  • New PIL for new product

Updated on 10 July 2015 PIL

Reasons for updating

  • Change to date of revision
  • Addition of information on reporting a side effect.

Updated on 10 July 2015 SmPC

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text
  • Improved electronic presentation

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 4.8 Undesirable effects, the following text has been added:

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important.  It allows continued monitoring of the benefit/risk balance of the medicinal product.  Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517.  Website: www.hpra.ie; E-mail:medsafety@hpra.ie.

In section 10 Date of revision of the text, the date has changed to "June 2015"

Updated on 13 October 2014 PIL

Reasons for updating

  • Change to date of revision
  • Removal/change of distributor

Updated on 20 January 2011 PIL

Reasons for updating

  • Change due to user-testing of patient information

Updated on 10 July 2007 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 6.3 - Shelf life
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 1: Text changed to "Exterol 5% w/w Ear Drops, Solution"
 
Section 2: Text added "For a full list of excipients, see section 6.1"
 
Section 3: Text changed to "Ear drops, solution. Clear, straw-coloured viscous solution" 
 
Section 6.3: Text added "Discard 4 weeks after first opening"
 
Section 6.4: Text changed to "Store upright. Do not store above 250C. Keep the bottle tightly closed. Keep the bottle in the outer carton"
 
Section 6.5: Text changed to "8 ml easy squeeze plastic dropper bottle with screw cap"
 
Section 6.6: Text changed to "No special requirements"
 
Section 9: Date changed to "28 January 2007"
 
Section 10: Date changed to "January 2007" 

Updated on 10 July 2007 PIL

Reasons for updating

  • Change of trade or active ingredient name
  • Change to storage instructions

Updated on 7 September 2004 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 19 June 2003 SmPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Supply through pharmacy only